{"id":"W4206483067","doi":"10.1016/j.jval.2021.11.759","title":"POSA244 First-Line Maintenance (1L MT) Treatment of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Western Europe (WE): Results of the CancerMPact® Survey 2020","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pembrolizumab; Pemetrexed; Carboplatin; Internal medicine; Oncology; Medicine; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006331942,0.0002515741,0.0003134437,0.0006697541,0.0001358008,0.0006011334,0.0003002265,0.0004446173,0.0009012647],"category_scores_gemma":[0.001102052,0.0001474981,0.0005319628,0.001977152,0.0001142167,0.0004803302,0.0004909175,0.0003491421,0.0004085793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004285351,"about_ca_system_score_gemma":0.0004641694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01765098,"about_ca_topic_score_gemma":0.02162696,"domain_scores_codex":[0.999581,0.00009584735,0.00005640059,0.0000741376,0.0001197638,0.00007287232],"domain_scores_gemma":[0.999388,0.00006550609,0.000288207,0.00002641475,0.0001014953,0.0001304278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003323868,0.0000783959,0.9914106,0.00005141192,0.0001502089,0.00003373123,0.00002675301,0.00009200993,0.0001502519,0.00002434872,0.00169545,0.00595453],"study_design_scores_gemma":[0.00001404853,0.00009546196,0.998518,0.0000140883,0.00006100785,0.00004840906,0.00005633867,0.00008518845,0.00004782956,0.00001123089,0.001046543,0.000001858528],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977241,0.001812866,0.0001301871,0.0003196311,0.00003019624,0.00002396296,0.01868695,0.00001405728,0.001741018],"genre_scores_gemma":[0.9710113,0.001281404,0.0001800238,0.0004003325,0.00003856751,0.00003857777,0.02557239,0.000006799232,0.001470567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01765098,"threshold_uncertainty_score":0.03509647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04938723913475337,"score_gpt":0.3179807771920575,"score_spread":0.2685935380573041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}